Empagliflozin Eliminates Refractory Ascites and Hepatic Hydrothorax in a Patient With Primary Biliary Cirrhosis

Am J Gastroenterol. 2021 Mar 1;116(3):618-619. doi: 10.14309/ajg.0000000000000995.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Ascites / drug therapy*
  • Ascites / etiology
  • Benzhydryl Compounds / therapeutic use*
  • Diabetes Mellitus, Type 2 / complications*
  • Female
  • Glucosides / therapeutic use*
  • Humans
  • Hydrothorax / drug therapy*
  • Hydrothorax / etiology
  • Liver Cirrhosis, Biliary / complications*
  • Middle Aged
  • Sodium-Glucose Transporter 2 Inhibitors / therapeutic use*
  • Treatment Outcome

Substances

  • Benzhydryl Compounds
  • Glucosides
  • Sodium-Glucose Transporter 2 Inhibitors
  • empagliflozin